The impact of external stress factors on hippocampus volume during antidepressant treatment

• I. Hrtanek ^[2] ; M. Bittsansky ^[1] ; I. Tonhajzerova ^[1] ; M. Grendar ^[1] ; M. Oppa ^[2] ; D. Cesnekova ^[2] ; I. Farsky ^[3] ; P. Hutka ^[2] ; D. Dobrota ^[4] ; K. Zelenak ^[5] ; I. Ondrejka ^[2]
  1. [1] Comenius University

     Comenius University

     Eslovaquia

     
  2. [2] Clinic of Psychiatry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital Martin. Martin. Slovakia
  3. [3] Clinic of Psychiatry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital Martin. Martin. Slovakia / Department of Nursing, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava. Martín. Slovakia
  4. [4] Department of Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava,Martin. Slovakia
  5. [5] Clinic of Radiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital Martin, Martin. Slovakia

  Mostrar afiliaciones +
• Localización: European journal of psychiatry, ISSN 0213-6163, Vol. 35, Nº 2, 2021, págs. 92-98
• Idioma: inglés
• Enlaces
  • Texto completo (pdf)
• Resumen

  • Background and objectives Magnetic resonance imaging (MRI) studies suggest that depression is associated with volumetric hippocampal changes. Investigations of these structures during antidepressant therapy is therefore important, however, volumetric studies are rare in this case. We aimed to study the effect of AD treatment on volumetric changes in hippocampus depending on stress factors in depressive patients.

    Methods Thirty patients with major depressive disorder (MDD) underwent MRI of the brain on the day of admission and at the time of stabilization of acute depressive symptomatology by venlafaxine. The presence of long-lasting stress factors in these patients was investigated by the social readjustment rating scale questionnaire.

    Results No significant differences were found in hippocampi volumes before and after venlafaxine treatment. However, regression analysis revealed significant positive relation between stress factors and volumetric hippocampus change during AD treatment.

    Conclusion It seems that antidepressant treatment by venlafaxine could be more suitable in the MDD patients with presence of stress-factors.